Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.61 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.61 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.48 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
| ▸ | NAAA | Q02083 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7515147 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL2877290 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL5812678 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL509990 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL9773213 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL7519047 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL6049889 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL1683717 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL7522764 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA | |
| SCHEMBL7517294 | 1.00 | GPR84 (0.61) | GPR84FFAR1ZDHHC7FFAR4NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025132660-A1 | METHOD FOR TREATING HUMAN PERSPIRATION, AND ASSOCIATED COMPOSITION | L'OREAL (FR) | 2025-06-26 | — | — | WO | disclosed |
| US-20250009621-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | L'OREAL (FR) | 2025-01-09 | — | — | US | disclosed |
| WO-2025006991-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | L'OREAL (FR) | 2025-01-02 | — | — | WO | disclosed |
| WO-2021195015-A1 | NOVEL 2-IN-1 SANITIZING AND RINSE AID COMPOSITIONS EMPLOYING AMINE BASED SURFACTANTS IN MACHINE WAREWASHING | ECOLAB USA INC. (US) | 2021-09-30 | — | — | WO | disclosed |
| EP-2757090-B1 | METHOD FOR PRODUCING N-ACYLAMINO TRIOL DERIVATIVES | KAO CORP (JP) | 2017-04-26 | — | — | EP | disclosed |
| EP-2757090-A1 | METHOD FOR PRODUCING N-ACYLAMINO TRIOL | Kao Corporation (JP) | 2014-07-23 | — | — | EP | disclosed |
| CN-103827079-A | Process for producing N-acylaminotriol | KAO CORP | 2014-05-28 | — | — | CN | disclosed |
| EP-0835864-B1 | A method of preparing primary amide derivatives | TAKASAGO PERFUMERY CO LTD (JP) | 2002-02-13 | — | — | EP | disclosed |
| US-5831125-A | Method of making primary amide derivative | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1998-11-03 | — | — | US | disclosed |
| EP-0835864-A2 | A method of preparing primary amide derivatives | Takasago International Corporation (JP) | 1998-04-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250009621-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | EBP, ADH1A, ADH1C | GPR84 205/4885FFAR1 234/4885ZDHHC7 1572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.